Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Cipher Pharmaceuticals Inc banner

Cipher Pharmaceuticals Inc
SWB:PHE

Watchlist Manager
Cipher Pharmaceuticals Inc Logo
Cipher Pharmaceuticals Inc
SWB:PHE
Watchlist
Price: 11.1 EUR 1.83% Market Closed
Market Cap: €60.9m
Write Note Create Alert Ask AI
USD
Metric FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Revenue
29.7m 40.1m 22.8m 22.5m 21.6m 21.9m 20.7m 21.2m 33.4m 50.5m
Cost of Revenue
(1.9m) (1.9m) (2.3m) (2.9m) (3.1m) (3.7m) (4m) (4.1m) (9.3m) (10m)
Gross Profit
27.7m 38.2m 20.4m 19.6m 18.6m 18.3m 16.7m 17.1m 24.1m 40.4m
Operating Expenses
(16.2m) (13.2m) (15.3m) (8m) (6.4m) (5.2m) (5.6m) (7.1m) (16.3m) (23.6m)
Selling, General & Administrative
(15.5m) (12.7m) (14.6m) (7.7m) (6.3m) (5.1m) (4.6m) (5.7m) (12.2m) (16.3m)
R&D
(570k) (390k) (560k) (400k) (130k) (90k) (100k) (139k) 0 (21k)
Depreciation & Amortization
(110k) (140k) (180k) — — — (990k) (1.2m) (4m) (7.2m)
Operating Income
11.5m 25.1m 5.1m 11.5m 12.2m 13.1m 11.1m 10m 7.8m 16.9m
Net Interest Income (Expense)
(5.8m) (5.2m) (180k) (880k) (200k) 10k 430k 2.6m (2.2m) 520k
Interest Expense
7.8m 5.3m 907k 965k 323k 92k — — 30k —
Non-Recurring Items
0 (5.8m) (1.8m) (4.9m) (5.4m) (1.3m) 0 — (2.7m) (352k)
Gain/Loss on Disposition of Assets
— — — — — (760k) 0 — — 130k
Pre-Tax Income
5.7m 14.1m 3.1m 5.7m 6.5m 11.1m 11.5m 12.7m 3m 17.2m
Tax Provision
(1.5m) (3.5m) (1.9m) (3.1m) (2.2m) (3.3m) 15.2m 7.7m 8.6m 10.2m
Income from Continuing Operations
4.2m 10.6m 1.2m 2.6m 4.4m 7.8m 26.6m 20.4m 11.5m 27.3m
Net Income
(39.2m) 4.3m 540k 3.2m 4.6m 7.8m 26.6m 20.4m 11.5m 27.3m
EPS (Diluted)
(1.49) 0.16 0.04 0.12 0.16 0.29 1.03 0.80 0.46 1.05
IMP
Imexpharm Corp

A scaled pharmaceutical manufacturer pairing steady margins with volatile working-capital cash flow

Intrinsic Value Access required
ACCENTMIC
Accent Microcell Ltd

A fast-growing excipient manufacturer entering a capital-intensive expansion phase

Intrinsic Value Access required
DCL
Cuu Long Pharmaceutical JSC

A pharmaceutical manufacturer with earnings pressure and working-capital-supported cash flow

Intrinsic Value Access required
TRA
Traphaco JSC

A profitable pharmaceutical manufacturer with rising capital intensity and working-capital sensitivity

Intrinsic Value Access required

Continue PHE Research

Summary
PHE intrinsic value, competitors valuation, and company profile.
DCF Valuation
PHE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PHE stock valuation using valuation multiples.
Wall St Estimates
PHE price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PHE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Cipher Pharmaceuticals Inc listings:
OTC • USD
CPHRF
 TSX • CAD
CPH
 F • EUR
PHE
ALPHA SPREAD
Follow us
Join 358,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.